Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Journal of Human Hypertension (3)
Nature (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Drug discovery
Health care

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: P Hasvold Clear advanced filters

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

ABBV-744, a selective inhibitor of the BD2 domains of BET family proteins, is effective against prostate cancer in mouse xenograft models, with lower toxicities than the dual-bromodomain BET inhibitor ABBV-075.

Emily J. Faivre
Keith F. McDaniel
Yu Shen
Research22 Jan 2020
Nature

Volume: 578, P: 306-310
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

S E Kjeldsen
J Stålhammar
D Russell
ResearchOpen Access05 Nov 2009
Journal of Human Hypertension

Volume: 24, P: 263-273
Health-care costs of losartan and candesartan in the primary treatment of hypertension

M Henriksson
D Russell
L-Å Levin
ResearchOpen Access08 Apr 2010
Journal of Human Hypertension

Volume: 25, P: 130-136
Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients

L P Hasvold
J Bodegård
S E Kjeldsen
ResearchOpen Access26 Jun 2014
Journal of Human Hypertension

Volume: 28, P: 663-669